CADL
CANDEL THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
CANDEL THERAPEUTICS INC (CADL) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$14.10M; the largest are Izzy Englander, Ken Griffin, Steven Cohen. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 3 added, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Heating up
Common-stock holders31 also report options
Congress trades0
Price$11.19vs quarter-end+8.64%
Sectors0
This quarter's moves
Top holderNew0
Added3
Trimmed / sold1
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $636.5K— of portfolio61,8002026 Q2
Value $454.2K— of portfolio44,1002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $636.5K | — | — |
| Ken GriffinCALL | $454.2K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.